PFE News 28.21 08/14/2014 05:31:00 Pfizer Inc (PFE)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pfizer Inc (PFE) 28.21 $PFE

Final Glance: Pharmaceuticals companies
AP - Wed Aug 13, 5:15PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:

Advisory Committee on Immunization Practices Votes to Recommend Pfizer's Prevnar 13(R) Vaccine in Adults Aged 65 Years and Older
Business Wire - Wed Aug 13, 4:43PM CDT
Pfizer Inc. (NYSE FE) today announced that the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) voted to recommend Prevnar 13(R) (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein])PCV13) for routine use to help protect adults aged 65 years and older against pneumococcal disease, which includes pneumonia caused by the 13 pneumococcal serotypes included in the vaccine. Specifically, the ACIP voted to recommend the following:

Midday Glance: Pharmaceuticals companies
AP - Wed Aug 13, 12:50PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:

Pfizer (PFE) Approaches New Upside Target of $28.49
Comtex SmarTrend(R) - Wed Aug 13, 10:43AM CDT
Pfizer (NYSE FE) has opened bullishly above the pivot of $28.16 today and has reached the first level of resistance at $28.28. Analysts will be watching for a cross of the next upside pivot targets of $28.49 and $28.82.

Early Glance: Pharmaceuticals companies
AP - Wed Aug 13, 9:32AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are up at 10 a.m.:

RiverVest Venture Partners' Otonomy Completes $100 Million Initial Public Offering
Business Wire - Wed Aug 13, 9:23AM CDT
Otonomy, a RiverVest Fund II portfolio company that develops drug therapies for the inner and middle ear, announced today its $100 million initial public offering.

Athersys Loss In Line with Expectations, Revenues Down Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 8:10AM CDT
Athersys, Inc. announced second quarter 2014 net loss of 9 cents (adjusting one-time items) per share.

Most active New York Stock Exchange-traded stocks
AP - Tue Aug 12, 5:11PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:

Business Highlights
By The Associated Press - AP - Tue Aug 12, 5:05PM CDT
___

UBS AG Contemplates $4.5B Bond Offerings in U.S. - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 12, 4:05PM CDT
As per Bloomberg, the Swiss major UBS AG (UBS) is planning corporate bond offerings in the U.S. The bank will be issuing $4.5 billion worth of bonds.

Pfizer Reports Top-line Results from Postherpetic Neuralgia and Painful Diabetic Peripheral Neuropathy Lyrica(R) Studies Conducted in China
Business Wire - Tue Aug 12, 4:02PM CDT
Pfizer Inc. (NYSE FE) announced today top-line results from two placebo-controlled studies conducted in China with Lyrica(R) (pregabalin) in patients with postherpetic neuralgia (pain after shingles or PHN) and painful diabetic peripheral neuropathy (pDPN), respectively. The PHN Phase 4 study, A0081276, met its primary endpoint by demonstrating a statistically significant reduction in pain when compared to placebo. Separately, the pDPN Phase 3 study, A0081265, did not meet its primary endpoint, a statistically significant change in endpoint mean pain score relative to placebo.

Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
PR Newswire Europe - Tue Aug 12, 12:50PM CDT
DUBLIN, Aug. 12, 2014 /PRNewswire/ -- Research and Markets [http://www.researchandmarkets.com/research/kpr76z/biological_drugs] has announced the addition of the "Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" [http://www.researchandmarkets.com/research/kpr76z/biological_drugs] report to their offering.

5 Things Pfizer Inc.'s Management Wants You to Know
Sean Williams, The Motley Fool - Motley Fool - Tue Aug 12, 12:27PM CDT
Big pharma giant Pfizer reported its second quarter earnings results two weeks ago, reminding shareholders that the patent cliff is very real, and that its operations are going through a sizable shift. For the quarter, Pfizer reported that...

Pfizer, 23andMe team up to study bowel disease
By MATTHEW PERRONE - AP - Tue Aug 12, 10:24AM CDT
WASHINGTON (AP) — Pfizer Inc. is teaming up with DNA testing company 23andMe to study the possible genetic underpinnings of inflammatory bowel disease, a hard-to-treat ailment that affects an estimated 1.4 million Americans.

Study Links Viagra(R) to Skin Cancer
Marketwire - Tue Aug 12, 10:20AM CDT
A recent study published in The Journal of the American Medical Association found that men who take Viagra® have an almost 84 percent greater risk of developing melanoma, one of the most aggressive forms of skin cancer. The study analyzed data from more than 25,000 men and controlled for factors such as sun exposure and family medical history.

Entia Biosciences' Supplements Could Prevent Dementia
ACCESSWIRE - Tue Aug 12, 8:55AM CDT
WHITEFISH, MT / ACCESSWIRE / August 12, 2014 / Vitamin D deficiency has been associated with a number of conditions, ranging from cardiovascular disease to certain types of cancers, according to WebMD. On the other side of the coin, research suggests that vitamin D could play a role in the prevention and treatment of diabetes, hypertension, glucose intolerance, multiple sclerosis, and a number of other serious medical conditions.

Pharma Equities Coverage -- Pfizer, BioDelivery Sciences Intl., The Medicines, Questcor Pharma, and Nektar Therapeutics
PR Newswire - Tue Aug 12, 8:00AM CDT
On Monday, August 11, 2014, the NASDAQ Composite ended at 4,401.33, up 0.70%, the Dow Jones Industrial Average advanced 0.10%, to finish the day at 16,569.98, and the S&P 500 closed at 1,936.92, up 0.28%. The gains were broad based as seven out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 700.04, up 0.01%, with the index also advancing 4.74 % in the previous three months. Investor-Edge has initiated coverage on the following equities: Pfizer Inc. (NYSE: PFE), BioDelivery Sciences International Inc. (NASDAQ: BDSI), The Medicines Company (NASDAQ: MDCO), Questcor Pharmaceuticals Inc. (NASDAQ: QCOR), and Nektar Therapeutics (NASDAQ: NKTR). Free research on these five companies can be accessed at:
Scroll down for more posts ▼

Top 10 Most Recent News Articles

RMT’s 12.4% Discount Still Demands a Much Harder Look

Updated Category News Views 119

A $1.84 gap is staring RMT shareholders right in the face. As of October 31, 2026, Royce Micro-Cap Trust carried a net asset value of $14.82 per share while the market price sat at $12.98. That is roughly a 12.4% discount to NAV, and closed-end fund investors should never wave off a spread like that with a lazy shrug. It may be opportunity. It may also be the market...

Continue Reading
Liquidity Services Faces a Brutal Revenue Reality Check

Updated Category News Views 23

A 19.17% opening haircut is the market ringing the fire alarm, not politely clearing its throat. Liquidity Services reported fiscal fourth-quarter revenue of $106.4 million, roughly 10% below the prior-year quarter, and shareholders got hit hard on November 19, 2026. That reaction is ugly, but it is not mysterious. When a company built around moving surplus inventory...

Continue Reading
IDEMIA Lands Sweden's Critical 5G Connectivity Job

Updated Category News Views 119

A hospital monitor going dark because a device was misprovisioned is not the kind of connectivity hiccup anybody gets to shrug off. That is why IDEMIA Secure Transactions winning the Region Västra Götaland assignment deserves more attention than the usual telecom plumbing announcement. The region is building what it calls Sweden's largest private 5G network, and the job...

Continue Reading
CustomerInsights.AI Fast 500 Nod Tests Its AI Model

Updated Category News Views 62

Pharma’s analytics mess is exactly where CustomerInsights.AI has chosen to make its stand. The Scottsdale company’s inclusion in Deloitte’s 2026 Technology Fast 500, announced November 19, is a useful signal that its pitch is finding buyers: life-sciences businesses want AI to do actual commercial work, not sit in a lab demo collecting dust. Still, a Fast 500 badge...

Continue Reading
TCL CSOT's Oxide Leap Gives LCD a Sharper Fight Ahead

Updated Category News Views 26

Fifty-one point six is the number that makes this announcement worth chewing on. TCL CSOT says it has moved ultrahigh-mobility oxide technology into mass production on an 8.6-generation line, clearing the 50 cm² V?¹ s?¹ threshold that has largely belonged to lab-talk and presentation slides. For display people, that is not decorative science. It could change the old...

Continue Reading
Retainers Are the Unflashy Finish to Orthodontic Care

Updated Category News Views 103

A straight smile has an inconvenient habit of remembering where it came from. That is the plainspoken point in Dr. Michael McClain’s discussion of retainers after braces or Invisalign: the dramatic part of orthodontic treatment may be over when appliances come off, but the maintenance phase has barely started. It is not glamorous, and plenty of people probably wish it...

Continue Reading
Prospera’s DFW Culture Win Matters Beyond the Plaque

Updated Category News Views 20

Employee survey ballots rarely make pulses race, but this one deserves more than a lazy shrug. Prospera Financial Services has landed on The Dallas Morning News’ 2026 Top Workplaces DFW list for a second consecutive year, placing in the Top Small Workplaces category. For a boutique independent broker-dealer, that is not meaningless wall décor. The people doing the...

Continue Reading
Blue Moon Closes Turner Deal, Eyes Nevada Mill Plan

Updated Category News Views 75

A shuttered Oregon copper-gold deposit just became part of Blue Moon’s puzzle, and the real question is whether the pieces can ever be made to fit cheaply enough to matter. Turner Adds a Nearby VMS Angle Blue Moon Metals has completed its acquisition of the Turner copper-gold deposit in O’Brien, Oregon, from Gold Coast Mining. The formal closing follows the September...

Continue Reading
AI Forces Learning Teams to Redefine Their Core Job

Updated Category News Views 108

Training Departments Are Not Sitting Still Corporate learning has spent years being treated like the office instruction manual, and AI is making that old arrangement look awfully flimsy. RedThread Research's November 19, 2026 study lands on a point that ought to make senior management pay attention: learning and development leaders are not merely waiting around to be...

Continue Reading
Green Lumber Recall Raises a Serious Safety Question

Updated Category News Views 41

A blister-pack code is doing far more work than it ever should. Green Lumber Holdings is recalling Green Lumber Natural Fuel For Men, lot GL01 with expiration 09/27, after FDA laboratory analysis confirmed undeclared tadalafil in additional samples. The company says the consumer-level recall begins November 19, 2026. This is not a cute labeling nitpick or a marketing...

Continue Reading

Top 5 Most Recently Viewed Articles

Harnessing AI for a Transformative Future in Human Resources

Updated Category News Views 193

The Impact of AI on Human Resources in 2026 As we look towards the future of work in 2026, the influence of artificial intelligence (AI) on human resources (HR) is undeniable. Businesses worldwide are adapting to an ecosystem increasingly shaped by AI, which plays a critical role in improving workforce efficiency. With insights from industry experts at ADP, organizations...

Continue Reading
Collins Aerospace Expands Executive Aircraft Seating Operations

Updated Category News Views 110

Collins Aerospace Expands Executive Aircraft Seating Operations Doubled production floor space and new machinery improves capacity and customization opportunities Collins Aerospace, a business unit of RTX (NYSE: RTX), is enhancing its executive aircraft seating facility with a significant $2 million investment. This expansion doubles the upholstery production floor space...

Continue Reading
Celebrating Success: Beyond Finance's Commitment to Clients

Updated Category News Views 345

Beyond Finance's Recognition for Outstanding Customer Service Beyond Finance, a leading name in the debt consolidation sector, proudly received the 2025 Excellence in Customer Service Award from the Business Intelligence Group. This accolade highlights the organization's unwavering commitment to transforming the lives of its clients by providing exceptional onboarding and...

Continue Reading
Understanding Bitcoin's Recent Price Fluctuations and Trends

Updated Category News Views 387

Bitcoin Faces Recent Price Challenges Bitcoin has experienced a 6% drop over the past month; nonetheless, it continues to be in a macro bull market. This resilience makes it outperform many other investment options as the cryptocurrency world evolves. What To Make of Recent Market Trends? Understanding Market Dynamics Notable crypto analyst Ali Martinez has pointed out...

Continue Reading
Chudnovsky Law Welcomes Brian D. Bill as New License Defense Attorney

Updated Category News Views 151

Chudnovsky Law's New Addition: Brian D. Bill Brian D. Bill has recently joined Chudnovsky Law, a distinguished law firm specializing in professional license defense. With California housing over 4.3 million licensed professionals, the need for expert defense in license investigations and enforcement cases is crucial. Brian D. Bill's Legal Background Mr. Bill brings...

Continue Reading